Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

Clinical trial NCT07281417 · RECRUITING

Trial details

NCT number: NCT07281417
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sinonasal Squamous Cell Carcinoma Stage III Sinonasal Cancer AJCC v8 Stage IVA Sinonasal Cancer AJCC v8 Stage IVB Sinonasal Cancer AJCC v8

Start date: 2026-11-24
Primary completion: 2030-12-16
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.